Sclerotherapy by Pilodocanol as the new treatment modality for aneurysmal bone cysts

Abstract

Objective: To ascertain the effectiveness of percutaneous sclerotherapy in the management of aneurysmal bone cyst. Material and method: Ten patients with aneurysmal bone cyst were treated by the percutaneous approach with pilodocanol in our institution Rohilkhand medical college and hospital Bareilly, from May 2018 to September 2020. The cysts were present in the lower limb. Under general anesthesia percutaneous sclerotherapy was done using computed tomography and fluoroscopy. 12 to 24 months (avg18 months) follow up for clinical and imaging was done and the outcomes were tabulated. Results: In five patients therapy was repeated 2-5 times. No failure was found in our series. There were some complications which included: local skin colour change, small blister and discharge. All patients got relieved. Conclusion: Percutaneous sclerotherapy of aneurysmal bone cyst with Polidocanol is fruitful and harmless. Thus a substitute to operative procedures, especially when it is unfeasible or not suggested in co-morbidity associated patients. Sclerotherapy is better than other treatment modality. If we can use sclerotherapy for non-reassessable sites then why we cannot use sclerotherapy in reassessable sites.